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Abstract
Background:  The effect of age on common carotid artery diameter is unclear for varying
atherosclerosis risk levels.
Methods: Cross-sectional data from the Atherosclerosis Risk in Communities Limited Access
Data set were used to estimate the association of age with B-mode ultrasound common carotid
artery diameter for three atherosclerosis risk levels. Based on information from clinical
examinations, B-mode ultrasounds, questionnaires, blood and other tests, participants were
categorized into three groups: pre-existing disease (prevalent stroke and/or coronary heart
disease), high risk group (no pre-existing disease, but prevalent diabetes, hypertension, plaques/
shadowing, body mass index >= 30, current smoking, or hyperlipidemia), and a low risk group (no
pre-existing disease, no plaques/shadowing, and no major elevated risk factors). Multivariable linear
regression analyses modeled the common carotid artery diameter relationship with age.
Results: Age was positively and significantly associated with common carotid artery diameter after
risk factor adjustment in the overall sample, but age had a larger effect among persons with
evidence of atherosclerosis (interaction p < 0.05). Each year of older age was associated with 0.03
mm larger diameter/year among persons with pre-existing disease, with 0.027 mm larger diameter/
year in the high risk group, but only 0.017 mm/year among the low risk group. Results were
qualitatively similar using plaques/shadowing status to indicate atherosclerosis severity.
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Conclusion: The significant impact of age on common carotid artery diameter among low risk,
middle-aged, black and white men and women suggests arterial remodelling may occur in the
absence of identified risk factors. The significantly larger impact of age among persons with,
compared to persons without identified atherosclerosis or its risk factors, suggests that arterial
remodelling may be an indicator of exposure duration.
Background
Because of its accessibility, the common carotid artery
(CCA) is often evaluated using B-mode ultrasound to
assess atherosclerosis severity [1-3]. Ultrasound, animal,
and anatomic studies indicate arterial diameters are asso-
ciated with hemodynamic factors [4-7] and with vascular
damage [8,9]. Several studies have suggested that arterial
wall area, or arterial diameter in conjunction with wall
thickness, may provide useful information for under-
standing atherosclerosis progression, vascular injury, or
vascular vulnerability [2,8,10-15]. However, the relation-
ship between arterial wall thickness and diameter is not
likely to be simple since both physiologic and pathologi-
cal processes can contribute to diameter differences [13].
For example multiple factors such as gender [16], physio-
logic response to shear stress[17] as well as plaque charac-
teristics [8,9] are known to be associated with arterial
diameter. So, many factors could potentially impact the
relationship between age and diameter. While many stud-
ies have evaluated associations of risk factors or vascular
characteristics with arterial diameter [8,9,11,18-23], fewer
studies have attempted to separate the effects of age and
atherosclerosis on arterial diameter. The Bruneck study
found that age was related to CCA diameter only in per-
sons within the upper 50th percentile of wall thickness
[11] while a small study of 69 male subjects screened for
the absence of atherosclerosis and its risk factors found
that diameter did increase significantly with age [13].
This study extends previous studies of B-mode ultrasound
CCA by estimating optimal B-mode ultrasound right CCA
diameters (interadventitial distances) within a low-risk
subset from a bi-racial population sample of both men
and women; by determining whether atherosclerosis
severity measures were effect modifiers of the age-CCA
diameter relationship; and by estimating the effect of age
among diseased, high risk, and low risk populations from
the same population sample.
Methods
Study sample
For our analyses we used the ARICLAD set provided by the
National Heart and Lung Institute (NHLBI) after the insti-
tutional review board at the University of Arkansas for
Medical Sciences approved the secondary data analysis as
having minimal risk to the participants within the Limited
Access Data set. The ARIC study was previously approved
by review boards at each institution involved in the origi-
nal study. The ARICLAD is a subset of the ARIC Cohort
Study, a population based study of atherosclerotic disease
in 15,792 black and non-black men and women, ages 45
to 64, from 4 clinical centers: Jackson, Mississippi; Forsyth
County, North Carolina; northwest Minneapolis suburbs;
and Washington County, Maryland. Participants from the
Jackson center were all black, about 14% of those from the
Forsyth center were black, and the other participants were
predominantly white (non-black) [24]. The sampling
strategy for the ARIC Cohort Study has been reported pre-
viously [24]. As per NHLBI policy [25], the ARICLAD set
excluded participants whose informed consents were not
consistent with release to investigators beyond the origi-
nal ARIC study, and after "records with personal identifi-
ers and other variables that might enable individual
participants to be identified, such as outliers, dates, and
study sites, were removed or otherwise modified" leaving
15,732 (99.6%) baseline participants. From this set, a
computer-generated random sample of 10,000 partici-
pants was chosen for a developmental data set, of which
9,109 participants had B-mode ultrasound diameter
measurements of the right common carotid artery (CCA).
B-mode ultrasound
At baseline, questionnaires were administered [24] and
fasting blood samples were drawn and processed as previ-
ously described [26]. Trained and certified sonographers
at each of the four ARIC clinical centers obtained B-mode
ultrasounds of the right and left carotid artery from three
carotid segments (CCA, bifurcation, and internal carotid
artery) with the participant in a supine position [27,28].
Each scan was read at a central reading center to achieve
maximal standardization of readings as previously
described [28]. This study evaluated the diameters (inter-
adventitial distances) obtained from the "optimal" angle
of interrogation of the distal 1 cm segment of the CCA (i.e.
the 1-cm segment proximal to the dilatation of the carotid
bulb). The "optimal" angle of interrogation was defined
as the longitudinal view that best displayed the Y-shaped
origin of the internal and external carotids from the
carotid bifurcation and the four interfaces needed to
define near and far wall thicknesses [27]. Since an earlier
study had shown coefficients describing the relationship
between CCA diameter and risk factors to be essentially
the same whether right, left, or both CCA diameters wereCardiovascular Ultrasound 2006, 4:1 http://www.cardiovascularultrasound.com/content/4/1/1
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used [29], we used the diameters from the right CCA
because more data were available.
Disease and subset definitions
Analyses were cross-sectional and evaluated either the
cohort sample or cohort subsets that were categorized
using baseline characteristics to represent populations
with varying prevalence of atherosclerotic disease and its
risk factors. The pre-existing disease subset was defined by
prevalence of either coronary heart disease (CHD) or
stroke at baseline. A high risk subset consisted of persons
without prevalent CHD or stroke, but with atherosclerotic
plaques/shadowing, diabetes, hypertension, obesity, cur-
rent smoking, or hyperlipidemia. Prevalent CHD was
based on electrocardiographic evidence of a myocardial
infarction (MI), self-reported physician diagnosis of a MI,
or history of a cardiac procedure at the baseline examina-
tion [30]. An algorithm based on a standardized, vali-
dated, stroke symptom questionnaire [31] and self-
reported diagnosis of stroke at baseline was used to iden-
tify prevalent stroke. Plaques or calcification (shadowing)
of the right or left carotid sites (internal, bifurcation, or
common carotid arteries) were identified based on B-
mode ultrasound wall shape, texture, and thickness as
described previously [28]. Other major risk factors at
baseline were identified as follows: prevalent diabetes
(self-reported physician diagnosis, medication within 2
weeks, or fasting blood glucose ≥ 126 mg/dL, or non-fast-
ing blood glucose ≥ 200 mg/dL); hypertension (anti-
hypertensive medication within 2 weeks or BP ≥ 140/90);
obesity (body mass index ≥ 30, computed as weight in kg
divided by height in meters2); current cigarette smoking
status; hyperlipidemia (LDL cholesterol ≥ 160 mg/dL and/
or use of cholesterol lowering medication). Cigarette years
of smoking were calculated as the product of the average
number of cigarettes smoked per day times the number of
years smoked. The low risk subset consisted of persons
remaining after excluding the pre-existing disease and
high risk subsets.
An alternative 2-level classification of atherosclerosis
severity, based on the presence or absence of atheroscle-
rotic plaques/shadowing, was evaluated in statistical
models with and without the first severity variables (pre-
existing disease and high risk status) with which there was
overlap. These analyses were limited to persons with
information on plaques or shadowing at any carotid site
(n = 7,381).
Statistical analysis
The analyses were performed using SAS v9.1.2 (SAS Insti-
tute Inc., Cary, N.C.). Baseline characteristics between dis-
ease severity groups were compared using one-way
analysis of variance (ANOVA) and chi-square tests. Multi-
ple linear regression analyses were used to determine both
the parameter estimates for age and for atherosclerosis
severity variables after adjustment for height, race, and
gender (basic adjustment) and after adding statistically
significant (p ≤ 0.05) atherosclerotic risk or preventive fac-
tors from the following list: body mass index (BMI),
hypertension, diabetes, systolic and diastolic blood pres-
sures (SBP and DBP), smoking status, drinking status,
usual grams of alcohol consumption per week, LDL and
HDL cholesterols, cholesterol lowering medication use,
white blood count, and fibrinogen. To test for effect mod-
ification, variables representing interaction terms between
age, gender, and race with variables for atherosclerosis
severity were tested and retained at an alpha of 0.05.
Adjustments were to the sample covariate means unless
specified otherwise. Age centering was used in conjunc-
tion with interaction terms to estimate the effects of
atherosclerosis severity at specific ages.
The gender-, height-, and age-specific means were esti-
mated with ordinary least squared regression models
adjusting for race (to the proportion in the low risk sub-
set). The 5th and 95th percentiles around the means were
estimated using quantile (percentile) regression available
in experimental SAS procedure QUANTREG.
Results
Of the 9,109 participants with right CCA diameter B-
mode ultrasound measurements, 8,528 participants had
adequate information for classification of disease severity
and 8,163 participants had data for risk adjustment.
Among persons with data from all 6 carotid sites (right or
left, internal, bifurcation, and CCA), 36% were found to
have plaque or shadowing (evidence of calcification) of at
least 1 site. The low risk, high risk, and pre-existing disease
groups were comprised of 1,397, 6175 and 591 partici-
pants respectively.
Characteristics of study population and subsets
Characteristics used to define the pre-existing disease,
high risk, and low risk subsets varied as expected (Table
1): smoking status, lipid profiles, and BP were most favo-
rable in the low risk group, and heart disease and stroke
were present only in the pre-existing group. However,
other characteristics varied as well. The mean age, propor-
tion of men, proportion of blacks, white blood count, and
fibrinogen values were lowest in the low risk subset and
were highest in the pre-existing disease subset except for
black race. The low risk subset also had the largest propor-
tion of current drinkers and the lowest ethanol consump-
tion reported by drinkers. The group with pre-existing
heart disease or stroke contained a greater proportion of
former smokers, former drinkers, diabetics, hypertensive
persons, users of cholesterol-lowering medication, and
persons with plaques/shadowing, but a smaller propor-
tion of current smokers, current drinkers, never smokers,Cardiovascular Ultrasound 2006, 4:1 http://www.cardiovascularultrasound.com/content/4/1/1
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Table 1: Characteristics of the cohort sample and the cohort subsets*: pre-existing disease, high risk, and low risk subsets, the 
Atherosclerosis Risk in Communities Cohort Limited Access Data, 1987–89.
Cohort Sample N = 8163‡ Subsets* of Cohort Sample
Pre-existing 
Disease
N = 591‡
High Risk
N = 6175‡
Low Risk
N = 1397‡
p-value
Age (mean, std) 54.2 (5.7) 56.5 (5.3) 54.4 (5.7) 52.2 (5.4) <0.0001
Male Gender (%) 44.8 64.3 44.8 36.7 <0.0001
Black Race (%) 25.5 25.5 28.7 12.3 <0.0001
Height in cm (mean, std) 168.5 (9.3) 170.4 (8.9) 168.4 (9.3) 168.0 (9.0) <0.0001
Stroke (%) 2.4 33.7† 0§ 0§ NA
Coronary Heart Disease 5.2 72.2† 0§ 0§ NA
Plaque or Shadowing 35.7 52.7 44.0† 0§ 0.0002
Smoker (%)
Current 26.9 29.6 32.8† 0§ 0.0783§§
Former 31.8 43.8 28.7 40.5
Never 41.3 26.6 38.5 59.5
Cigarette Years for Current Smokers (mean, std) 681.9 (438.9) 845.3 (532.4) 667.7 (427.1) N/A <0.0001
Drinker (%)
Current 56.3 48.6 55.4 63.4 <0.0001§§
Former 19.3 31.5 19.1 14.9
Never 24.4 20.0 25.5 21.7
Ethanol g/wk for Current Drinkers (mean, std) 76.3 (119.1) 87.8 (125.5) 81.1 (125.8) 54.1 (81.9) <0.0001
Diabetes (%) 11.4 22.3 12.9† 0§ <0.0001
Hypertension (%) 35.5 54.3 41.7† 0§ <0.0001
Cholesterol Medication Use (%) 3.0 6.5 3.3† 0§ <0.0001
Body Mass Index (mean, std) 27.7 (5.3) 28.2 (5.4) 28.3 (5.5)† 24.7 (2.8) <0.0001
Systolic Blood Pressure mm Hg (mean, std) 121.4 (18.7) 122.7 (21.6) 123.5 (19.0)† 111.5 (12.0) <0.0001
Diastolic Blood Pressure mm Hg (mean, std) 73.7 (11.3) 72.6 (12.5) 74.8 (11.5)† 69.6 (8.5) <0.0001
LDL Cholesterol mg/dl (mean, std) 138.2 (39.5) 145.2 (39.5) 142.5 (40.3)† 116.2 (26.0) <0.0001
HDL Cholesterol mg/dl (mean, std) 51.5 (17.0) 44.6 (15.9) 50.4 (16.2) 59.2 (18.7) <0.0001
Fibrinogen (mean, std) 304.3 (65.3) 321.9 (72.0) 308.6 (65.0) 277.5 (55.5) <0.0001
White Blood Count (thousands) (mean, std) 6.2 (2.1) 6.7 (3.3) 6.3 (2.0) 5.4 (1.5) <0.0001
*Subsets: Pre-existing disease = prevalent CHD or stroke; High risk = absence of pre-existing disease + either diabetes, hypertension, body mass 
index ≥ 30, current cigarette smoking, LDL cholesterol ≥ 160 mg/dL, use of cholesterol lowering medication, or presence of plaque or shadowing 
on B-mode ultrasound; Low risk = absence of pre-existing disease and risk factors.
Percentages may not total to 100% because of rounding.
‡N = maximum possible in the cohort or subsets. For some variables, smaller numbers are available because of missing values.
†Variable levels were used to distinguish between the high risk factor and low risk subsets.
N/A since smokers were excluded from low risk subset.
§Subset was defined by the absence of the characteristic.
§§Comparison of equality of proportions of current smokers and current drinkers between groups.
and never drinkers than the high risk group. The pre-exist-
ing disease group also had a less favorable lipid profile
(higher LDL and lower HDL), a lower DBP, and higher
cigarette years smoked for current smokers than the high
risk subset.
Age-diameter relationships: adjustment to study 
population means
When disease severity dummy variables (pre-existing dis-
ease, high risk status) were used as indicators of athero-
sclerosis severity, the risk-adjusted models retained age,
race, height, BMI, current smoker status and cigarette years
of smoking, current drinker status and usual ethanol
intake, SBP, and DBP, and fibrinogen. When interactions
were tested, the age-diameter relationships were not the
same among the pre-existing disease, high risk and low
risk subsets (p < 0.05 for deviance tests comparing models
with and without interaction terms). Therefore, interac-
tion terms (age-high risk status and age-pre-existing dis-
ease status) were retained and independent variable betas
are shown in Table 2.
In basic models (Table 2), men (beta = 0.492) and blacks
(beta = 0.19) had significantly larger CCA diameters than
women and whites respectively. Height (beta = 0.02) was
significantly and positively associated with CCA diameter
as well. Adjusting for atherosclerotic risk factors (Table 2,
full model) resulted in a reduction of the effect sizes asso-
ciated with race (beta = 0.087) and gender (beta = 0.435)Cardiovascular Ultrasound 2006, 4:1 http://www.cardiovascularultrasound.com/content/4/1/1
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by approximately 54% and 12% respectively, but did not
reduce the effect of height (beta = 0.023).
In the basic model, each year of older age was associated
with almost 0.03 mm larger CCA diameter (Table 2, age
main effect) in the low risk subset, but the age effect was
larger among the diseased (main effect + interaction term
= 0.046 mm/year) and high risk subsets (main effect +
interaction term = 0.039 mm/year) (Table 2). Not shown
in the table is that by age 64, CCA diameters were 0.602
mm (SE = 0.077) larger in the pre-existing disease and
0.427 mm (SE = 0.056) larger in the high risk subsets than
in the low risk subset prior to risk adjustment (both p <
0.0001). After risk factor adjustment, the betas were mark-
edly reduced but still significant (beta = 0.252 and beta =
0.14 for the pre-existing disease and high risk group
respectively, both p < 0.01). Except for current drinking
status and DBP, all covariates were positively associated
with CCA diameter (Table 2).
Age-diameter relationships: separate models adjusting to 
young-age risk levels
Results were similar when the relationship between age
and diameter was determined for each subset in separate
analyses (Figure 1). Betas for covariates were determined
in linear regression models for each subset. Each stratified
analysis was then adjusted to the means/proportions for
the covariates of persons who were 45 to 50 years old in
the respective subsets. Older age was associated with
larger diameters in all subsets regardless of the level of
adjustment, but the effect of age was reduced by risk factor
adjustment in all subsets (slopes decreased after adjust-
ment). Diameters for the pre-existing disease and high risk
groups were larger than the low risk group, regardless of
the level of adjustment. After risk factor adjustment, there
was little difference between the slopes for the pre-existing
disease and high risk groups (pre-existing disease: 0.028
mm/year; high risk group: 0.027 mm/year), but both
groups continued to have slightly greater slopes than the
low risk group (0.020 mm/year).
Age-diameter relationships: plaque/shadowing as indicator 
of atherosclerosis severity
The alternative measure of atherosclerosis severity
(plaque/shadowing presence or absence) was also found
to be an effect modifier of the age-CCA diameter relation-
ship in both basic (p = 0.01) and risk factor adjusted mod-
els (p = 0.02). After basic adjustment, age was positively
associated with CCA diameter (0.035 mm/year) when
plaques were absent (p < 0.0001) and with an additional
Table 2: Beta coefficients and 95% confidence intervals (CI) for multivariable linear regression models with CCA diameter as the 
outcome after adjustment for basic covariates and after adding atherosclerotic risk factors.* Both models included interaction terms 
allowing determination of effects of age in subsets of varying atherosclerosis severity†, the Atherosclerosis Risk in Communities 
(ARIC) Limited Data Set, 1987–1989
Basic Model N = 8163 Full Model N = 8163
Beta (95% CI) p-value Beta (95% CI) p-value
Main effects
Male gender 0.492 (0.439, 0.545)‡ <0.0001 0.435 (0.384, 0.486)‡ <0.0001
Black race/ethnicity 0.190 (0.149, 0.231)‡ <0.0001 0.087 (0.044, 0.130)‡ <0.0001
Height (cm) 0.020 (0.018, 0.022)‡ <0.0001 0.023 (0.021, 0.025)‡ <0.0001
Current smoking - 0.154 (0.107, 0.201)‡ <0.0001
Current drinking - -0.038 (-0.075, -0.001)‡ 0.0485
Cigarette years of smoking (in 100's) - 0.019 (0.015, 0.023)‡ <0.0001
Ethanol (100 grams/week) - 0.039 (0.021, 0.057)‡ <0.0001
BMI - 0.025 (0.021, 0.029)‡ <0.0001
Systolic BP - 0.017 (0.015, 0.019)‡ <0.0001
Diastolic BP - -0.013 (-0.015, -0.011)‡ <0.0001
Fibrinogen - 0.0002 (0.0000, 0,0004)‡ 0.0335
Age (1 year of age) 0.028 (0.020, 0.036)† <0.0001 0.017 (0.009, 0.025)† <0.0001
Additional diameter increase per year of age
Among Diseased Subset 0.018 (0.004, 0.032)§ 0.0139 0.013 (-0.001, 0.027)§ 0.0611
Among Risk Factor Subset 0.011 (0.003, 0.019)§§ 0.0096 0.011 (0.003, 0.019)§§ 0.0101
* Basic model independent variables = age, race, gender, height, dummy variables for disease severity, and interaction terms between age-disease 
severity dummy variables. Full model added variables = BMI, systolic and diastolic blood pressures, current smoker status, cigarette years of 
smoking in hundreds, current drinker status and grams of ethanol usually consumed per week in 100 g, fibrinogen value.
‡Beta indicates the expected difference in millimeters of CCA diameter associated with the presence of each categorical variable and for each unit 
increase of continuous variables.
†Beta indicates the expected difference in millimeters of CCA diameter for each year of older age in the low risk subset.
§-§§Betasindicate the expected difference in millimeters of CCA diameter associated with each year of age among the diseased (§) and risk factor or 
high risk (§§) subsets.Cardiovascular Ultrasound 2006, 4:1 http://www.cardiovascularultrasound.com/content/4/1/1
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0.009 mm/year when plaques were present (p = 0.0145).
Risk factor adjustment reduced the effect of age for per-
sons without plaques (beta = 0.021, SE = 0.002, p <
0.0001) and reduced the added age effect found when
plaques were present (beta = 0.008, SE = 0.003, p = 0.02).
Models with plaque/shadowing and disease/risk status
In statistical models with basic adjustment but no interac-
tion terms, plaque/shadowing status, and pre-existing dis-
ease and high risk status were significantly associated with
CCA diameter (p < 0.0001). The addition of risk factors
(current smoking status and cigarette years of smoking,
drinking status and ethanol consumption, body mass
index, fibrinogen, and SBP and DBP) resulted in a loss of
significance of pre-existing disease (beta = 0.022, SE =
0.044, p = 0.6) and high risk status (beta = -0.039, SE =
0.028, p = 0.16), but not in plaque status (beta = 0.148,
SE = 0.021, p < 0.0001). After adjustment, plaque status
remained a significant modifier of the age effect on diam-
eter (p < 0.03).
Estimates of age-, gender-, and height-specific right CCA 
diameter
Age had the smallest impact on the right CCA diameter
among the low risk subset. Table 3 provides the gender-,
height-, and age-specific mean diameters and correspond-
ing percentiles for the low risk subset after adjusting for
race. Right CCA diameters were larger for men, for tall per-
sons, and for older persons compared to their respective
counterparts.
Discussion
This study provides estimates for the effect of age on the
right CCA diameter in both low and high risk popula-
tions. As an estimate of optimal right CCA diameters for
middle-aged adults, the study provides age-, gender- and
height-specific estimates for right CCA diameters from a
low risk subset of the ARICLAD. Our findings of a signifi-
cant, positive association between age and CCA diameter
among a low risk population, with a larger effect among
persons with atherosclerotic disease or high levels of risk
factors, suggest that arterial remodeling may indicate
duration of exposure among persons with atherosclerosis
or elevated risk factors and duration of "normal" stresses
among persons with low risk factor levels.
That atherosclerosis and atherosclerotic risk factors are
associated with arterial diameter is well recognized
[7,20,29,32], and recent studies have suggested arterial
remodelling frequently occurs in association with vulner-
able plaques [8,9,14]. So, associations between age and
arterial diameter may not reflect the contribution of age
itself, but instead, an increase in prevalence and/or sever-
ity of atherosclerosis or its risk factors with increasing age.
The prospective Bruneck study, comprised of a random
sample of men and women 40 to 85 years old, found a
statistically significant increase in CCA diameter with age
for persons in the highest 50th percentile of wall thickness,
but a much smaller and non-significant diameter increase
among persons with thinner CCA walls [11]. Similarly,
our study found a larger effect of age on CCA diameter in
persons with pre-existing atherosclerotic disease or high
cardiovascular risk factor levels compared to low risk per-
sons (e.g. without atherosclerotic disease and with low
Age-specific, adjusted B-mode ultrasound common carotid artery diameters for study subsets, ARIC Limited Access data,  1987–89 Figure 1
Age-specific, adjusted B-mode ultrasound common carotid artery diameters for study subsets, ARIC Limited Access data, 
1987–89. *Age-specific diameters were estimated for each risk subset using betas determined from stratified models after 
adjusting for basic variables (race, sex, and height) and after adding risk factors (body mass index, SBP, DBP, current smoker 
status, usual ethanol intake (gms/week), fibrinogen, and years of smoking). **Adjustment was to the covariate means/propor-
tions of persons age 45 to 50 of each subset. Diamonds indicate pre-existing disease subset; triangles indicate high risk subset; 
squares indicate low risk subset; Solid symbols indicate basic adjustment and open symbols indicate risk factor adjustment.Cardiovascular Ultrasound 2006, 4:1 http://www.cardiovascularultrasound.com/content/4/1/1
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Table 3: The age-specific means and 5th and 95th percentiles for men and women by height categories, adjusted for race* determined 
from low risk participants of the ARIC Limited Access Data set, 1987–89.
Men
Height <170 cm Height 170–179 cm Height 180+ cm
Age Mean 
Diameter
Diameter Percentiles Mean 
Diameter
Diameter Percentiles Mean 
Diameter
Diameter Percentiles
5th 95th 5th 95th 5th 95th
45 7.45 6.60 8.15 7.59 6.74 8.85 7.84 6.91 8.90
46 7.48 6.62 8.19 7.62 6.75 8.90 7.86 6.90 8.92
47 7.51 6.65 8.23 7.65 6.76 8.94 7.88 6.88 8.95
48 7.53 6.68 8.28 7.69 6.78 8.99 7.90 6.86 8.98
49 7.56 6.70 8.32 7.72 6.79 9.04 7.92 6.85 9.00
50 7.59 6.73 8.36 7.75 6.80 9.08 7.95 6.83 9.03
51 7.61 6.76 8.40 7.78 6.81 9.13 7.97 6.81 9.05
52 7.64 6.78 8.45 7.81 6.83 9.18 7.99 6.80 9.08
53 7.67 6.81 8.49 7.84 6.84 9.22 8.01 6.78 9.11
54 7.69 6.83 8.53 7.87 6.85 9.27 8.03 6.76 9.13
55 7.72 6.86 8.58 7.91 6.86 9.32 8.05 6.75 9.16
56 7.75 6.89 8.62 7.94 6.88 9.36 8.07 6.73 9.19
57 7.77 6.91 8.66 7.97 6.89 9.41 8.09 6.71 9.21
58 7.80 6.94 8.70 8.00 6.90 9.46 8.11 6.70 9.24
59 7.83 6.97 8.75 8.03 6.91 9.50 8.13 6.68 9.26
60 7.85 6.99 8.79 8.06 6.93 9.55 8.15 6.66 9.29
61 7.88 7.02 8.83 8.09 6.94 9.60 8.17 6.65 9.32
62 7.91 7.05 8.88 8.13 6.95 9.64 8.19 6.63 9.34
63 7.93 7.07 8.92 8.16 6.96 9.69 8.21 6.62 9.37
64 7.96 7.10 8.96 8.19 6.98 9.74 8.23 6.60 9.39
Women
Height <160 cm Height 160–169 cm Height 170+ cm
Age Mean 
Diameter
Diameter Percentiles Mean 
Diameter
Diameter Percentiles Mean 
Diameter
Diameter Percentiles
5th 95th 5th 95th 5th 95th
45 6.82 6.13 7.75 6.93 6.09 7.93 7.15 6.17 8.10
46 6.84 6.13 7.77 6.97 6.12 7.96 7.18 6.20 8.15
47 6.86 6.13 7.79 7.0 6.15 7.99 7.21 6.22 8.21
48 6.88 6.14 7.81 7.03 6.18 8.02 7.25 6.25 8.26
49 6.90 6.14 7.83 7.06 6.21 8.06 7.28 6.28 8.31
50 6.93 6.14 7.85 7.10 6.24 8.09 7.31 6.30 8.37
51 6.95 6.15 7.87 7.13 6.27 8.12 7.35 6.33 8.42
52 6.97 6.15 7.89 7.16 6.29 8.15 7.38 6.36 8.47
53 6.99 6.15 7.91 7.20 6.32 8.18 7.41 6.39 8.53
54 7.01 6.16 7.93 7.23 6.35 8.22 7.45 6.41 8.58
55 7.03 6.16 7.94 7.26 6.38 8.25 7.48 6.44 8.63
56 7.05 6.16 7.96 7.30 6.41 8.28 7.51 6.47 8.69
57 7.08 6.17 7.98 7.33 6.44 8.31 7.55 6.49 8.74
58 7.10 6.17 8.00 7.36 6.47 8.35 7.58 6.52 8.79
59 7.12 6.17 8.02 7.39 6.50 8.38 7.61 6.55 8.85
60 7.14 6.18 8.04 7.43 6.53 8.41 7.64 6.57 8.90
61 7.16 6.18 8.06 7.46 6.56 8.44 7.68 6.60 8.95
62 7.18 6.18 8.08 7.49 6.59 8.48 7.71 6.63 9.00
63 7.20 6.19 8.10 7.53 6.62 8.51 7.74 6.66 9.06
64 7.23 6.19 8.12 7.56 6.65 8.54 7.78 6.68 9.11
*Diameters adjusted to the same proportion of black participants (13%)Cardiovascular Ultrasound 2006, 4:1 http://www.cardiovascularultrasound.com/content/4/1/1
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CVD risk factor levels). In our study, the greater effect of
age on the CCA diameter in the higher risk groups was
driven by the presence of atherosclerotic plaques. In con-
trast to the Bruneck study, our study found a significant
positive association between age and CCA diameter even
in the low risk subset. A number of differences between
the studies could explain the discrepant findings: our
study evaluated cross-sectional data and the Bruneck
study evaluated prospective data; our study was of the
right CCA and the Bruneck study combined right and left
CCA; different criteria were used to define the low risk
groups; and the study populations were different. How-
ever, qualitatively, results from the two studies are similar.
CCA did increase with age in the Bruneck study low risk
group, just not significantly so. Another study evaluated
69 male patients and athletes, aged 16–75, who were
selected for the absence of major atherosclerotic risk fac-
tors and plaque [13]. In this convenience sample, age was
a strong independent predictor of CCA diastolic diameter.
Each ten years of increasing age was associated with a 0.17
mm larger CCA diameter [13], which is similar to the esti-
mate in persons without atherosclerotic plaques (0.02
mm/year) and identical to the risk factor adjusted esti-
mate from our low risk subset (0.017 mm/year). These
findings support an effect for aging that is separate from
that of clinically identifiable atherosclerosis and which
appears to be relatively uniform in middle aged popula-
tions without major risk factors.
The significant interactions between both atherosclerosis
severity measures and age in models predicting CCA
diameter are consistent with age being a marker for length
of exposure to the damaging risk factor effects. However,
a significant interaction persisted only between age and
plaques after adjustment for risk factors suggesting that
much of the greater age effect in the pre-existing disease
and high risk groups occur because of the effect of athero-
sclerotic damage evidenced by the presence of plaques.
The low risk subset was selected so that subjects had risk
factor values lower than those typically used to identify
cardiovascular risk. The reduction in the parameter esti-
mate for age's impact on CCA diameter in the low risk
group after adjusting for continuous atherosclerotic risk
factors, indicates that even risk factor levels not com-
monly classified as detrimental can impact CCA diame-
ters. This is not surprising given previous findings for BP
[33]. Thus, at least part of the CCA diameter differences
seen with older age in this low risk group was likely due to
higher (though still normal) atherosclerosis risk factor
levels at older ages. The persistence of a significant, posi-
tive association between age and CCA diameter in the low
risk population, even after adjustment for atherosclerotic
risk factors, suggests that damage or weakening of the arte-
rial wall associated with aging also contributes to diame-
ter enlargement. Since the primary goal of the ARIC
ultrasound examination was not to identify plaques, we
cannot exclude the possibility that some of the CCA diam-
eter enlargement, even in the low risk group, was due to
underlying atherosclerosis which was not identified.
This difference in diameters among the low risk group and
higher risk groups has important implications for defin-
ing normal values in general. Since the prevalence of obes-
ity and associated risk factors is high in many populations
[34-36], using population based samples could result in
incorrect estimations of optimal values for CCA diameter
and other risk factors influenced by obesity. Thus, persons
at risk could be misclassified as being normal, and the
possibility of misclassification could be largest in popula-
tions with the greatest obesity and risk.
Because the study is cross-sectional in design, the associa-
tions that were identified do not necessarily indicate a
causal mechanism. The division into low risk, high risk
and pre-existing disease groups is somewhat arbitrary; and
so, results could reflect differences because of the ages rep-
resented within the risk groups. However, given that sub-
stantial proportions of all age categories 45–49, 50–54,
55–59, and 60–64 were represented within each risk
group, age differences are unlikely to be driving the find-
ings. Persons who had missing information leading to
their exclusion in the current study were different in a
number of ways from the persons available for study.
However, since the associations for age and CCA diameter
were quantitatively similar to those reported by for a
smaller "normal" male population and qualitatively sim-
ilar to those reported in a prospective study [11,13], our
results are likely to provide reasonable estimates for the
differences that would be found in populations with dis-
parate atherosclerotic risk.
Conclusion
In conclusion, consistent with our hypothesis and previ-
ous studies, our cross-sectional results indicate that per-
sons with pre-existing atherosclerotic disease or
atherosclerosis risk factors have larger diameters than per-
sons without those attributes. More importantly, we also
found that the impact of each year of older age on CCA
diameter was significantly larger among populations with
pre-existing cardiovascular disease and among persons
with high risk factor levels or plaques compared to those
at low risk of atherosclerotic disease and we were able to
quantify the expected effect. Future investigations should
consider the relationship between age, length of risk fac-
tor exposure, diameter, wall thickness, plaque, and dis-
ease development to better understand the progression of
atherosclerosis and development of cardiovascular dis-
ease.Cardiovascular Ultrasound 2006, 4:1 http://www.cardiovascularultrasound.com/content/4/1/1
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